Prime Living & Health seeks a buyer 100% stake in company put up for sale
Translated by Kim So-in 공개 2021-07-21 08:00:10
이 기사는 2021년 07월 21일 07:56 thebell 에 표출된 기사입니다.
Prime Living & Health, the South Korean company behind dietary supplement for men Vmax, has been put up for sale.Prime Living & Health has hired Samil PwC to manage the process to sell a 100% stake owned by president Choi Young-sik, industry sources said on Monday. The seller is carrying out marketing campaign by distributing teaser letters to potential buyers, including private equity firms.
Founded in 2011, Prime Living & Health is a male dietary supplements distribution company. The company recorded revenue of 30 billion won ($26 million) with a single product in just two years, thanks to Vmax’s popularity.
The company’s revenue jumped 386% to 47.2 billion won and its operating profit increased 626% to 14.4 billion won last year, backed by its diversified product lineup and the Covid-19 pandemic.
Prime Living & Health boosted its operating profit margin by running its own marketing center. The company has generated 90% of its sales through its marketing center instead of using homeshopping and open market channels which require high commission fees. But its reliance on Vmax is considered a weakness, with the company generating 90% of total sales from Vmax.
Prime Living & Health signed memorandum of understanding with DanDi Bioscience in March to develop and distribute health functional food that enhances immunity and body functions. It plans to launch new dietary supplements for men.
The seller is emphasizing the company’s growth potential to be the top-tier firm in the men’s dietary supplements market. The size of the domestic health functional food market was 4.9 trillion won in 2020, a 6.6% increase from the previous year, according to data from the Korea Health Supplements Association. The men’s health supplement market is estimated at around 1 trillion won.
Several private equity firms are currently showing interest in the company, with a strategic investor which intends to expand its business into the health supplement sector may consider a possible acquisition. (Reporting by Se-hun Jo)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- 라온시큐어, 공공기관 아이폰 보안관리솔루션 요건 충족
- [Company Watch] 갈 길 먼 삼성 파운드리, '적자탈출' 언제쯤
- [피플人 제약바이오]국제약품의 '안질환' 타깃, CTO가 밝힌 이유있는 자신감
- 씨이랩, 국제인공지능대전서 영상 특화 AI 제품 소개
- 보령, 카나브에 케이캡까지…매출 1조 목표에 '성큼'
- [수술대 오른 커넥트웨이브]8000억 투입하는 MBK, 높아진 엑시트의 벽
- KB운용, 외부서 인력 또 영입…내부 불만 고조
- '52주 최저가 근접' 티에스아이, 풋옵션 물량 부담
- 비브스튜디오스, 광주 백운광장 '인터렉티브 콘텐츠'
- 분쟁에도 끄떡없는 한미약품, 두자릿수 영업이익률 저력